BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 43
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8293)
All Articles published online
The chart showing PDF series, HTML series.
Item 
Count 
PDF755
HTML5592
 Sum=6347
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1000
Download943
 Sum=1943
Nov 21, 2013 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Nitzan O, Elias M, Chazan B, Raz R, Saliba W. Clostridium difficile and inflammatory bowel disease: Role in pathogenesis and implications in treatment. World J Gastroenterol 2013; 19(43): 7577-7585 [PMID: 24282348 DOI: 10.3748/wjg.v19.i43.7577]
URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7577.htm
Number Citing Articles
1
Gabriela Muniz Carvalho, Carolina Pantuzza Ramos, Francisco Carlos Faria Lobato, Roberto Maurício Carvalho Guedes, Paula Roberta Giaretta, Rodrigo Otávio Silveira Silva. Laboratory diagnosis of Clostridioides (Clostridium) difficile infection in domestic animals: A short review. Anaerobe 2022; 75: 102574 doi: 10.1016/j.anaerobe.2022.102574
2
Maria J. G. T. Vehreschild, Surabhi Taori, Simon D. Goldenberg, Florian Thalhammer, Emilio Bouza, Joop van Oene, Graham Wetherill, Areti Georgopali. Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE). European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(11): 2097 doi: 10.1007/s10096-018-3344-1
3
Iulia-Magdalena Vasilescu, Mariana-Carmen Chifiriuc, Gratiela Gradisteanu Pircalabioru, Roxana Filip, Alexandra Bolocan, Veronica Lazăr, Lia-Mara Diţu, Coralia Bleotu. Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.651081
4
S. R. Stockdale, R. S. Harrington, A. N. Shkoporov, E. V. Khokhlova, K. M. Daly, S. A. McDonnell, O. O’Reagan, J. A. Nolan, D. Sheehan, A. Lavelle, L. A. Draper, F. Shanahan, R. P. Ross, C. Hill. Metagenomic assembled plasmids of the human microbiome vary across disease cohorts. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13313-y
5
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020;  doi: 10.1017/9781316823026
6
Meng Yang, Shambhunath Bose, Soo-Kyoung Lim, Hojun Kim. Preventive Effects of Pyungwi-san against Dextran Sulfate Sodium- and Clostridium difficile-Induced Inflammatory Bowel Disease in Mice. International Journal of Molecular Sciences 2019; 20(24): 6346 doi: 10.3390/ijms20246346
7
Nabarun Chandra Das, Ritwik Patra, Atrayee Dey, Suprabhat Mukherjee. Prebiotics, Probiotics and Nutraceuticals. 2022; : 69 doi: 10.1007/978-981-16-8990-1_5
8
Christoph Högenauer, Yashwant Mahida, Andreas Stallmach, Philippe Marteau, Grazyna Rydzewska, Vladimir Ivashkin, Panagiotis Gargalianos-Kakolyris, Ingrid Michon, Nicholas Adomakoh, Areti Georgopali, Reiner Tretter, Andreas Karas, Walter Reinisch. Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE). Journal of Antimicrobial Chemotherapy 2018; 73(12): 3430 doi: 10.1093/jac/dky368
9
E. A. Kozhukhova, I. V. Gorbova. Characteristics of acute diarrhea adult cases with samples positive for Norwalk virus. Russian Journal of Infection and Immunity 2019; 9(2): 375 doi: 10.15789/2220-7619-2019-2-375-380
10
Gabrio Bassotti, Alessandro Fruganti, Giovanni Maconi, Pierfrancesco Marconi, Katia Fettucciari. Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease May be Favoured by the Effects of Proinflammatory Cytokines on the Enteroglial Network. Journal of Inflammation Research 2021; : 7443 doi: 10.2147/JIR.S328628
11
Mark Mattar. Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infections: Our Experience in Patients with and without Inflammatory Bowel Disease. Gastroenterology & Hepatology: Open Access 2015; 3(1) doi: 10.15406/ghoa.2015.03.00071
12
Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk. Introduction to Gastrointestinal Diseases Vol. 1. 2017; : 83 doi: 10.1007/978-3-319-49016-8_6
13
Zhaoxiu Liu, Hui Song, Bo Shen. Pouchitis. Current Opinion in Clinical Nutrition and Metabolic Care 2014; 17(5): 489 doi: 10.1097/MCO.0000000000000094
14
Fang Liu, Jianan Liu, Thomas T.Y. Wang, Zhen Liu, Changhu Xue, Xiangzhao Mao, Qingjuan Tang, Robert W. Li. Molecular and Microbial Signatures Predictive of Prebiotic Action of Neoagarotetraose in a Dextran Sulfate Sodium-Induced Murine Colitis Model. Microorganisms 2020; 8(7): 995 doi: 10.3390/microorganisms8070995
15
Meryem T. Ok, Jintong Liu, R. Jarrett Bliton, Caroline M. Hinesley, Ekaterina Ellyce T. San Pedro, Keith A. Breau, Ismael Gomez-Martinez, Joseph Burclaff, Scott T. Magness. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early Clostridioides difficile toxin exposure. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 324(4): G262 doi: 10.1152/ajpgi.00251.2022
16
Nitsan Maharshak, Idan Barzilay, Hasya Zinger, Keren Hod, Iris Dotan. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease. Medicine 2018; 97(5): e9772 doi: 10.1097/MD.0000000000009772
17
Nobuaki Mori, Jun Hirai, Wataru Ohashi, Nobuhiro Asai, Yuichi Shibata, Hiroshige Mikamo. Derivation of clinical predictive factors (CHIEF) for first recurrent Clostridioides difficile infection. American Journal of Infection Control 2024; 52(4): 419 doi: 10.1016/j.ajic.2023.10.004
18
Xingwei Ding, Wenyan Jiang, Menghuan Li, Shiyu Xiong, Wei Wei, Mingzhuo Liu, Hongbo Xin, Zhong Luo, Yanli Zhao. An ROS/DAMP dual-scavenging nanomedicine for normalizing macrophage polarization and microbiome in colitis. Nano Today 2023; 51: 101924 doi: 10.1016/j.nantod.2023.101924
19
F.-C. Huang, S.-C. Huang. The different effects of probiotics treatment on Salmonella-induced interleukin-8 response in intestinal epithelia cells via PI3K/Akt and NOD2 expression. Beneficial Microbes 2016; 7(5): 739 doi: 10.3920/BM2015.0181
20
Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Paula Anderco, Sabrina Birsan. Fecal Microbiota Transplantation in Inflammatory Bowel Disease. Biomedicines 2023; 11(4): 1016 doi: 10.3390/biomedicines11041016
21
Alexandra Firek, Kelsey Warren, Carina Lorenzen, Lorena P Bonilla MD. Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Rare Case Involving Mandibular, Elbow, and Pubic Ulcers. Journal of Brown Hospital Medicine 2024; 3(1) doi: 10.56305/001c.90522
22
Abhishek Deshpande, Chaitanya Pant, Mojtaba Olyaee, Curtis J. Donskey. Hospital readmissions related to Clostridium difficile infection in the United States. American Journal of Infection Control 2018; 46(3): 346 doi: 10.1016/j.ajic.2017.08.043
23
Min-zheng Zhu, Mei-feng Yang, Yang Song, Hao-ming Xu, Jing Xu, Ning-ning Yue, Yuan Zhang, Cheng-mei Tian, Rui-yue Shi, Yu-jie Liang, Jun Yao, Li-sheng Wang, Yu-qiang Nie, De-feng Li. Exploring the efficacy of herbal medicinal products as oral therapy for inflammatory bowel disease. Biomedicine & Pharmacotherapy 2023; 165: 115266 doi: 10.1016/j.biopha.2023.115266
24
David B. Stewart. The ASCRS Textbook of Colon and Rectal Surgery. 2016; : 929 doi: 10.1007/978-3-319-25970-3_53
25
Alberto Cózar-Llistó, Antonio Ramos-Martinez, Javier Cobo. Clostridium difficile Infection in Special High-Risk Populations. Infectious Diseases and Therapy 2016; 5(3): 253 doi: 10.1007/s40121-016-0124-z
26
Beth Faiman. Diarrhea in Multiple Myeloma: A Review of the Literature. Clinical Journal of Oncology Nursing 2016; 20(4): E100 doi: 10.1188/16.CJON.E100-E105
27
Sarah Larcombe, Melanie L. Hutton, Dena Lyras. Involvement of Bacteria Other Than Clostridium difficile in Antibiotic-Associated Diarrhoea. Trends in Microbiology 2016; 24(6): 463 doi: 10.1016/j.tim.2016.02.001
28
Beth Faiman, Deborah Doss, Kathleen Colson, Patricia Mangan, Tracy King, Joseph Tariman, and Board
. Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma. Clinical Journal of Oncology Nursing 2017; 21(5): 19 doi: 10.1188/17.CJON.S5.19-36
29
Diego Montoya-Cerrillo, Anas Bernieh, Ali G. Saad. Critical diagnoses in paediatric gastrointestinal diseases. Pathology 2022; 54(2): 195 doi: 10.1016/j.pathol.2021.09.023
30
James Kuo, Jasmina Uzunovic, Amanda Jacobson, Michelle Dourado, Sarah Gierke, Manohary Rajendram, Daniela Keilberg, Jordan Mar, Emily Stekol, Joanna Curry, Sofia Verstraete, Jessica Lund, Yuxin Liang, Fiona B Tamburini, Natalie S Omattage, Matthieu Masureel, Steven T Rutherford, David H Hackos, Man-Wah Tan, Allyson L Byrd, Mary E Keir, Elizabeth Skippington, Kelly M Storek. Toxigenic Clostridium perfringens Isolated from At-Risk Paediatric Inflammatory Bowel Disease Patients. Journal of Crohn's and Colitis 2024;  doi: 10.1093/ecco-jcc/jjae016
31
Hong Yang, Zhihua Ran, Meng Jin, Jia-Ming Qian. Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study. Gut and Liver 2022; 16(5): 726 doi: 10.5009/gnl210217
32
Amin Ariaee, Sabrina Koentgen, Hannah R Wardill, Georgina L Hold, Clive A Prestidge, Heather K Armstrong, Paul Joyce. Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence. eGastroenterology 2024; 2(2): e100055 doi: 10.1136/egastro-2023-100055
33
Pedro Palacios Argueta, Miguel Salazar, Bashar Attar, Roberto Simons-Linares, Bo Shen. 90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors. Inflammatory Bowel Diseases 2021; 27(4): 530 doi: 10.1093/ibd/izaa224
34
Fenfen Zhou, Therwa Hamza, Ashley S Fleur, Yongrong Zhang, Hua Yu, Kevin Chen, Jonathon E Heath, Ye Chen, Haihui Huang, Hanping Feng. Mice with Inflammatory Bowel Disease are Susceptible toClostridium difficileInfection With Severe Disease Outcomes. Inflammatory Bowel Diseases 2018; 24(3): 573 doi: 10.1093/ibd/izx059
35
Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis. World Journal of Pediatrics 2022; 18(1): 27 doi: 10.1007/s12519-021-00486-1
36
Ziyu Yang, Juanxiu Qin, Lina Zhao, Tianchi Chen, Qian Huang, Ying Jian, Qi Zhao, Sheng Yang, Qi Li, Qian Liu, Michael Otto, Min Li. Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease. Gastroenterology 2023; 164(7): 1189 doi: 10.1053/j.gastro.2023.02.046
37
Beth Faiman, Deborah Doss, Kathleen Colson, Patricia Mangan, Tracy King, Joseph Tariman, and Board
. Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma. Clinical Journal of Oncology Nursing 2017; 21(5): 19 doi: 10.1188/17.CJON.S5.3-6
38
Zeina Z. Berro, Righab H. Hamdan, Israa H. Dandache, Mohamad N. Saab, Hussein H. Karnib, Mahmoud H. Younes. Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1571-6
39
Niloufar Roshan, Katherine A. Hammer, Thomas V. Riley. Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection. Anaerobe 2018; 49: 103 doi: 10.1016/j.anaerobe.2018.01.003
40
Rishi Mahajan, Shalini Chandel, Gunjan Goel. Food Safety and Preservation. 2018; : 457 doi: 10.1016/B978-0-12-814956-0.00015-9
41
Ying M. Tang, Christian D. Stone. Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment. Clinical Journal of Gastroenterology 2017; 10(2): 112 doi: 10.1007/s12328-017-0719-2
42
Mei Bai, Hong Guo, Xiao-Yao Zheng. Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231207280
43
Andreas M. Kaiser, Rachel Hogen, Liliana Bordeianou, Karim Alavi, Paul E. Wise, Ranjan Sudan. Clostridium Difficile Infection from a Surgical Perspective. Journal of Gastrointestinal Surgery 2015; 19(7): 1363 doi: 10.1007/s11605-015-2785-4
44
Trusha Nana, Chanelle Moore, Tom Boyles, Adrian J. Brink, Joy Cleghorn, Lesley M. Devenish, Briette du Toit, Ernst S. Fredericks, Molebogeng R. Lekalakala-Mokaba, Caroline Maluleka, Muhammad N. Rajabally, Gary Reubenson, Liliwe Shuping, Karin Swart, Khine Swe Swe Han, Jeannette Wadula, Justyna Wojno, Warren Lowman. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. Southern African Journal of Infectious Diseases 2020; 35(1) doi: 10.4102/sajid.v35i1.219
45
Brandon M Shore, Kimberly N Weaver, Jessica R Allegretti, Hans H Herfarth, Edward L Barnes. Prevalence of Clostridioides difficile Infection After Ileal Pouch-anal Anastomosis in Patients With Chronic Antibiotic-dependent Pouchitis and Crohn’s-like Disease of the Pouch. Inflammatory Bowel Diseases 2023; 29(6): 932 doi: 10.1093/ibd/izac165
46
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; : 388 doi: 10.1017/9781316823026.024
47
Triana Lobatón, Eugeni Domènech. Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile. Inflammatory Bowel Diseases 2016; 22(7): 1755 doi: 10.1097/MIB.0000000000000788
48
Orna Nitzan, Mazen Elias, Avi Peretz, Walid Saliba. Role of antibiotics for treatment of inflammatory bowel disease. World Journal of Gastroenterology 2016; 22(3): 1078-1087 doi: 10.3748/wjg.v22.i3.1078
49
Hiroyuki Kunishima, Hiroki Ohge, Hiromichi Suzuki, Atsushi Nakamura, Kazuaki Matsumoto, Hiroshige Mikamo, Nobuaki Mori, Yoshitomo Morinaga, Katsunori Yanagihara, Yuka Yamagishi, Sadako Yoshizawa. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. Journal of Infection and Chemotherapy 2022; 28(8): 1045 doi: 10.1016/j.jiac.2021.12.011
50
Joseph D. Forrester, Lawrence Z. Cai, Chenesa Mbanje, Tanya N. Rinderknecht, Sherry M. Wren. Clostridium difficile infection in low‐ and middle‐human development index countries: a systematic review. Tropical Medicine & International Health 2017; 22(10): 1223 doi: 10.1111/tmi.12937
51
Kelly R. Reveles, Eric M. Mortensen, Jim M. Koeller, Kenneth A. Lawson, Mary Jo V. Pugh, Sarah A. Rumbellow, Jacqueline R. Argamany, Christopher R. Frei. Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2018; 38(3): 349 doi: 10.1002/phar.2088
52
Dana J Lukin, Garrett Lawlor, David P Hudesman, Laura Durbin, Jordan E Axelrad, Monica Passi, Kimberly Cavaliere, Elliot Coburn, Michelle Loftus, Henry Jen, Alexandra Feathers, Melissa H Rosen, Lisa B Malter, Arun Swaminath. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection WithClostridium difficile. Inflammatory Bowel Diseases 2019; 25(4): 775 doi: 10.1093/ibd/izy308
53
Staffan Sandell, Mamun-Ur Rashid, Christina Jorup-Rönström, Kristina Ellström, Carl Erik Nord, Andrej Weintraub. Clostridium difficile recurrences in Stockholm. Anaerobe 2016; 38: 97 doi: 10.1016/j.anaerobe.2016.01.005
54
Abin Chandrakumar, Hussein Zohni, Wael El-Matary. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020; 26(11): 1700 doi: 10.1093/ibd/izz285
55
Henry Wade, Kaichao Pan, Qihua Duan, Szczepan Kaluzny, Ekta Pandey, Linda Fatumoju, Viswanathan Saraswathi, Rongxue Wu, Edward N. Harris, Qiaozhu Su. Akkermansia muciniphila and its membrane protein ameliorates intestinal inflammatory stress and promotes epithelial wound healing via CREBH and miR-143/145. Journal of Biomedical Science 2023; 30(1) doi: 10.1186/s12929-023-00935-1
56
A. K. Li, M. Barton, J. A. Delport, D. Ashok. Edwardsiella tardaInfection Triggering Acute Relapse in Pediatric Crohn’s Disease. Case Reports in Infectious Diseases 2019; 2019: 1 doi: 10.1155/2019/2094372
57
Angelina Di Re, Yi Liang, Martijn Pieter Gosselink, Grahame Ctercteko. Acute Gastroenteritis in the Etiology of Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Crohn's & Colitis 360 2021; 3(4) doi: 10.1093/crocol/otab065
58
Winnie C. Mutai, Marianne Mureithi, Omu Anzala, Brian Kullin, Robert Ofwete, Cecilia Kyany’ a, Erick Odoyo, Lillian Musila, Gunturu Revathi, Ben Pascoe. Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya. PLOS Global Public Health 2022; 2(1): e0000090 doi: 10.1371/journal.pgph.0000090
59
Masoumeh Azimirad, Abbas Yadegar, Fatemeh Gholami, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Gianluca Ianiro, Hidekazu Suzuki, Giovanni Cammarota, Mohammad Reza Zali. <p>Treatment of Recurrent <em>Clostridioides difficile</em> Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease</p>. Journal of Inflammation Research 2020; : 563 doi: 10.2147/JIR.S265520
60
Hualiang Pi, Rong Sun, James R. McBride, Angela R. S. Kruse, Katherine N. Gibson-Corley, Evan S. Krystofiak, Maribeth R. Nicholson, Jeffrey M. Spraggins, Qiangjun Zhou, Eric P. Skaar. Clostridioides difficile ferrosome organelles combat nutritional immunity. Nature 2023; 623(7989): 1009 doi: 10.1038/s41586-023-06719-9
61
Lise Lurienne, Pierre-Alain Bandinelli, Thibaut Galvain, Charles-Alexis Coursel, Caterina Oneto, Paul Feuerstadt. Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey. Journal of Patient-Reported Outcomes 2020; 4(1) doi: 10.1186/s41687-020-0179-1
62
Eugenia Bruzzese, Antonietta Giannattasio, Alfredo Guarino. Antibiotic treatment of acute gastroenteritis in children. F1000Research 2018; 7: 193 doi: 10.12688/f1000research.12328.1
63
Dipesh Solanky, Darrell S Pardi, Edward V Loftus, Sahil Khanna. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflammatory Bowel Diseases 2019; 25(3): 610 doi: 10.1093/ibd/izy291
64
Thomas Edward Conley, Joseph Fiske, Sreedhar Subramanian. How to manage: acute severe colitis. Frontline Gastroenterology 2022; 13(1): 64 doi: 10.1136/flgastro-2020-101710
65
Oscar L Hernandez, Zoilo K Suarez, Talwinder Nagi, Charles Vallejo, Allison Ferris. Dormant Crohn's Disease Reactivated by Clostridioides difficile Infection. Cureus 2023;  doi: 10.7759/cureus.37062
66
Ruiqiao He, Pan Li, Jinfeng Wang, Bota Cui, Faming Zhang, Fangqing Zhao. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2100197
67
D. S. Purgina, L. V. Lyalina, V. V. Rassokhin. Clostridium diffi cile infection and its eff ect on the course of infl ammatory bowel diseases. Clinical Medicine (Russian Journal) 2022; 100(7-8): 346 doi: 10.30629/0023-2149-2022-100-7-8-346-356
68
Young-Jin Son, Young-Rok Kim, Sang-Hun Oh, Sungji Jung, Marco A. Ciufolini, Hee-Jong Hwang, Jin-Hwan Kwak, Hyunjoo Pai. Micrococcin P2 Targets Clostridioides difficile. Journal of Natural Products 2022; 85(8): 1928 doi: 10.1021/acs.jnatprod.2c00120
69
Xiaohan Xu, Yuelun Zhang, Jia Gan, Xiangyang Ye, Xuerong Yu, Yuguang Huang. Association between perioperative allogeneic red blood cell transfusion and infection after clean-contaminated surgery: a retrospective cohort study. British Journal of Anaesthesia 2021; 127(3): 405 doi: 10.1016/j.bja.2021.05.031
70
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease 2018; 50(8): 741 doi: 10.1016/j.dld.2018.04.020
71
Huajing Qiu, Xiaomin Sun, Mingming Sun, Chong He, Zhong Li, Zhanju Liu. Serum bacterial toxins are related to the progression of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2014; 49(7): 826 doi: 10.3109/00365521.2014.919018
72
Josef Neu. Probiotics and Necrotizing Enterocolitis. Clinics in Perinatology 2014; 41(4): 967 doi: 10.1016/j.clp.2014.08.014
73
Alexander Khoruts, Kevin M. Rank, Krista M. Newman, Kimberly Viskocil, Byron P. Vaughn, Matthew J. Hamilton, Michael J. Sadowsky. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Clinical Gastroenterology and Hepatology 2016; 14(10): 1433 doi: 10.1016/j.cgh.2016.02.018
74
Mukta Gupta, Bhupinder Kapoor, Monica Gulati. Bacterial consortia-The latest arsenal to inflammatory bowel disease bacteriotherapy. Medicine in Microecology 2024; 20: 100107 doi: 10.1016/j.medmic.2024.100107
75
Preethi G. Venkat, Nghia H. Nguyen, Jiyu Luo, Alexander S. Qian, Sahil Khanna, Siddharth Singh. Impact of recurrent hospitalization for Clostridioides difficile on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort. Therapeutic Advances in Gastroenterology 2022; 15: 175628482211415 doi: 10.1177/17562848221141501
76
Daniela Simian, Daniela Flux&aacute;, Lilian Flores, Jaime Lubascher, Patricio Ib&aacute;ñez, Carolina Figueroa, Udo Kronberg, Ra&uacute;l Acuña, Mauricio Moreno, Rodrigo Quera. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World Journal of Gastroenterology 2016; 22(22): 5267-5275 doi: 10.3748/wjg.v22.i22.5267
77
O. M. Drapkina, L. B. Lazebnik, I. G. Bakulin, M. S. Zhuravleva, N. V. Bakulina, E. V. Skazyvaeva, S. I. Sitkin, M. I. Skalinskaya, O. I. Solovyeva, E. Yu. Eremina, S. V. Tikhonov, T. S. Fil', T. L. Pilat, Yu. G. Kuznetsova, R. A. Khanferyan, M. A. Livzan, M. F. Osipenko, D. I. Abdulganieva, L. V. Tarasova, A. I. Khavkin. <i>Clostridioides difficile</i> infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists. Experimental and Clinical Gastroenterology 2023; (2): 4 doi: 10.31146/1682-8658-ecg-210-2-4-32
78
Tanya M. Monaghan, Alan Cockayne, Yashwant R. Mahida. Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(8): 1957 doi: 10.1097/MIB.0000000000000461
79
Hirotaka Igarashi, Shingo Maeda, Koichi Ohno, Ayako Horigome, Toshitaka Odamaki, Hajime Tsujimoto, Bryan A. White. Effect of Oral Administration of Metronidazole or Prednisolone on Fecal Microbiota in Dogs. PLoS ONE 2014; 9(9): e107909 doi: 10.1371/journal.pone.0107909
80
E. A. Kozhukhova, I. V. Gorbova, N. V. Andreeva, V. D. Ivashchenko. CLINICAL INFORMATIVE VALUE IN THE DIAGNOSTIC TESTING FOR DETECTION OF ROTAVIRUS INFECTIONS IN ADULT PATIENTS WITH ACUTE DIARRHEA. The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University 2018; 25(3): 54 doi: 10.24884/1607-4181-2018-25-3-54-61
81
Petros Zezos, Fred Saibil. Inflammatory pouch disease: The spectrum of pouchitis. World Journal of Gastroenterology 2015; 21(29): 8739-8752 doi: 10.3748/wjg.v21.i29.8739
82
Seth A. Reasoner, Irtiqa F. Fazili, Rachel Bernard, Jacob M. Parnell, Andrew G. Sokolow, Kelly F. Thomsen, Kathryn M. Edwards, Rebekah F. Brown, Maribeth R. Nicholson. Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis. Journal of Cystic Fibrosis 2023; 22(5): 884 doi: 10.1016/j.jcf.2022.12.014
83
Sibel Bolukcu, IsmailNecati Hakyemez, BilgeSumbul Gultepe, Gulay Okay, Bulent Durdu, MelihaMeric Koc, Turan Aslan. Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile. Saudi Journal of Gastroenterology 2019; 25(6): 0 doi: 10.4103/sjg.SJG_44_19
84
Dania Comparcini, Valentina Simonetti, Francesco Vladimiro Segala, Francesco Di Gennaro, Davide Fiore Bavaro, Maria Antonietta Pompeo, Annalisa Saracino, Giancarlo Cicolini. Nurses’ Knowledge, Attitudes and Practices on the Management of Clostridioides difficile Infection: A Cross-Sectional Study. Antibiotics 2023; 12(3): 529 doi: 10.3390/antibiotics12030529
85
Alexander Khoruts, Alexa R. Weingarden. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. Immunology Letters 2014; 162(2): 77 doi: 10.1016/j.imlet.2014.07.016
86
Grace O. Androga, Julie Hart, Niki F. Foster, Adrian Charles, David Forbes, Thomas V. Riley, G. A. Land. Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis. Journal of Clinical Microbiology 2015; 53(11): 3702 doi: 10.1128/JCM.01810-15
87
Meeta Desai, Kristin Knight, James M. Gray, Vu Nguyen, James Boone, Dario Sorrentino. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1099 doi: 10.1097/MEG.0000000000001762
88
Kelsey Shields, Roger V. Araujo-Castillo, Thimmaiah G. Theethira, Carolyn D. Alonso, Ciaran P. Kelly. Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe 2015; 34: 59 doi: 10.1016/j.anaerobe.2015.04.012
89
Ebrahim Rahimi, Zahra Sadat Afzali, Zeinab Torki Baghbadorani. Clostridium difficile in ready-to-eat foods in Isfahan and Shahrekord, Iran. Asian Pacific Journal of Tropical Biomedicine 2015; 5(2): 128 doi: 10.1016/S2221-1691(15)30156-8
90
Christopher T. Aquina, Christian P. Probst, Adan Z. Becerra, Bradley J. Hensley, James C. Iannuzzi, Katia Noyes, John R. T. Monson, Fergal J. Fleming. High Variability in Nosocomial Clostridium difficile Infection Rates Across Hospitals After Colorectal Resection. Diseases of the Colon & Rectum 2016; 59(4): 323 doi: 10.1097/DCR.0000000000000539
91
Marta Gravito-Soares, Elisa Gravito-Soares, Francisco Portela, Manuela Ferreira, Carlos Sofia. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4819/2016
92
Ergenekon Karagoz, Alpaslan Tanoglu. Clinical importance of serum procalcitonin in ulcerative colitis patients. World Journal of Gastroenterology 2014; 20(42): 15941-15942 doi: 10.3748/wjg.v20.i42.15941
93
Hamidreza Houri, Abbas Yadegar, Mohammad Reza Zali. How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?. Digestive Diseases and Sciences 2021; 66(9): 2849 doi: 10.1007/s10620-020-06667-8
94
Sarah Rotondo‐Trivette, Beibei Wang, Christopher Gayer, Riddhi Parsana, Yihui Luan, Fengzhu Sun, Sonia Michail. Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection. Alimentary Pharmacology & Therapeutics 2021; 54(6): 792 doi: 10.1111/apt.16496
95
Triana Lobatón, Ilse Hoffman, Severine Vermeire, Marc Ferrante, Jan Verhaegen, Gert Van Assche. Aeromonas Species. Inflammatory Bowel Diseases 2015; 21(1): 71 doi: 10.1097/MIB.0000000000000247
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345